Report - Canadian Regulatory Perspective on Subsequent …2008/01/18  · Canadian Regulatory Perspective on Subsequent-Entry Biologics (Biosimilars) Anthony Ridgway, Ph.D. Senior Regulatory

Please pass captcha verification before submit form